Meanwhile, our MyDay toric parameter expansion across North America and Europe is performing nicely ... Moving to our ...

Biofinity and Avaira had another strong quarter in Q4 ... When I look at MyDay toric, the expanded range, love to get that in more markets and increase availability by a multifocal, love to ...